An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus (vol 426, pg 186, 2003)

被引:7
作者
Lamarre, D
Anderson, PC
Bailey, M
Beaulieu, P
Bolger, G
Bonneau, P
Bös, M
Cameron, DR
Cartier, M
Cordingley, MG
Faucher, AM
Goudreau, N
Kawai, SH
Kukolj, G
Lagacé, L
Laplante, SR
Narjes, H
Poupart, MA
Rancourt, J
Sentjens, RE
St George, R
Simoneau, B
Steinmann, G
Thibeault, D
Tsantrizos, YS
Weldon, SM
Yong, CL
Llinàs-Brunet, M
机构
关键词
D O I
10.1038/nature02183
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Nature 426, 186–189 (2003). In this Letter, the ‘Competing interests statement’ should be corrected to: ‘The authors declare competing financial interests: R.E.S. was the clinical investigator and received an honorarium from Boehringer Ingelheim. All the other authors are or were employees of Boehringer Ingelheim.
引用
收藏
页码:314 / 314
页数:1
相关论文
共 1 条
[1]   An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus [J].
Lamarre, D ;
Anderson, PC ;
Bailey, M ;
Beaulieu, P ;
Bolger, G ;
Bonneau, P ;
Bös, M ;
Cameron, DR ;
Cartier, M ;
Cordingley, MG ;
Faucher, AM ;
Goudreau, N ;
Kawai, SH ;
Kukolj, G ;
Lagacé, L ;
LaPlante, SR ;
Narjes, H ;
Poupart, MA ;
Rancourt, J ;
Sentjens, RE ;
St George, R ;
Simoneau, B ;
Steinmann, G ;
Thibeault, D ;
Tsantrizos, YS ;
Weldon, SM ;
Yong, CL ;
Llinàs-Brunet, M .
NATURE, 2003, 426 (6963) :186-189